Literature DB >> 23065300

Classes of psychotic experiences in Kenyan children and adolescents.

Daniel Mamah1, Akinkunle Owoso, Anne W Mbwayo, Victoria N Mutiso, Susan K Muriungi, Lincoln I Khasakhala, Deanna M Barch, David M Ndetei.   

Abstract

Psychotic-like experiences (PLEs) have been observed worldwide in both adults and children outside the context of a clinical disorder. In the current study, we investigate the prevalence and patterns of PLEs among children and adolescents in Kenya. Among 1,971 students from primary and secondary schools around Nairobi (aged 8-19), 22.1 % reported a lifetime history of a psychotic experience, and 16.3 % reported this unrelated to sleep or drugs. Psychotic experiences were more common in males compared to females. LCA resulted in a three-class model comprised of a normative class (83.3 %), a predominately hallucinatory class (Type 1 psychosis: 9.6 %), and a pan-psychotic class (Type 2 psychosis: 7.2 %). These results indicate that PLEs are prevalent in children and adolescents, and the distributions of symptom clusters are similar to that found in adulthood. The relationship of specific PLEs to the future development of psychotic disorder, functional impairment or distress will require further study.

Entities:  

Mesh:

Year:  2013        PMID: 23065300      PMCID: PMC3568190          DOI: 10.1007/s10578-012-0339-5

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  46 in total

1.  Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample.

Authors:  C Morgan; H Fisher; G Hutchinson; J Kirkbride; T K Craig; K Morgan; P Dazzan; J Boydell; G A Doody; P B Jones; R M Murray; J Leff; P Fearon
Journal:  Acta Psychiatr Scand       Date:  2008-12-01       Impact factor: 6.392

2.  Screening for psychosis in the general population with a self-report interview.

Authors:  W W Eaton; A Romanoski; J C Anthony; G Nestadt
Journal:  J Nerv Ment Dis       Date:  1991-11       Impact factor: 2.254

3.  Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis.

Authors:  I Kelleher; M Cannon
Journal:  Psychol Med       Date:  2010-05-19       Impact factor: 7.723

4.  Psychotic-like experiences are associated with violent behavior in adolescents.

Authors:  Yoshihiro Kinoshita; Shinji Shimodera; Atsushi Nishida; Kuni Kinoshita; Norio Watanabe; Norihito Oshima; Tatsuo Akechi; Tsukasa Sasaki; Shimpei Inoue; Toshi A Furukawa; Yuji Okazaki
Journal:  Schizophr Res       Date:  2010-09-15       Impact factor: 4.939

5.  Psychotic symptoms in non-clinical populations and the continuum of psychosis.

Authors:  Hélène Verdoux; Jim van Os
Journal:  Schizophr Res       Date:  2002-03-01       Impact factor: 4.939

6.  The ABC Schizophrenia Study: a preliminary overview of the results.

Authors:  H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-08       Impact factor: 4.328

Review 7.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder.

Authors:  J van Os; R J Linscott; I Myin-Germeys; P Delespaul; L Krabbendam
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

8.  Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study.

Authors:  J Welham; J Scott; G Williams; J Najman; W Bor; M O'Callaghan; J McGrath
Journal:  Psychol Med       Date:  2008-07-08       Impact factor: 7.723

9.  Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.

Authors:  Ian Kelleher; Michelle Harley; Aileen Murtagh; Mary Cannon
Journal:  Schizophr Bull       Date:  2009-06-19       Impact factor: 9.306

10.  Psychotic-like experiences and depressive symptoms in a community sample of adolescents.

Authors:  M Barragan; K R Laurens; J B Navarro; J E Obiols
Journal:  Eur Psychiatry       Date:  2011-02-21       Impact factor: 5.361

View more
  6 in total

1.  Cross-country variations in the reporting of psychotic symptoms among sub-Saharan African adults: A psychometric evaluation of the Psychosis Screening Questionnaire.

Authors:  Mary Bitta; Yanga Thungana; Hannah H Kim; Christy A Denckla; Amantia Ametaj; Mahlet Yared; Claire Kwagala; Linnet Ongeri; Rocky E Stroud; Edith Kwobah; Karestan C Koenen; Symon Kariuki; Zukiswa Zingela; Dickens Akena; Charles Newton; Lukoye Atwoli; Solomon Teferra; Dan J Stein; Bizu Gelaye
Journal:  J Affect Disord       Date:  2022-02-18       Impact factor: 6.533

2.  Validation of the Launay-Slade Hallucination Scale among Indian Healthy Adults.

Authors:  Sushree Sahu; Vikas Sharma; Sara Siddi; Antonio Preti; Deepak Malik; Siddharth Singhania; Triptish Bhatia; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2020-08-19

3.  A comparative study of psychotic and affective symptoms in Rwandan and Kenyan students.

Authors:  A Owoso; S Jansen; D M Ndetei; A Musau; V N Mutiso; C Mudenge; A Ngirababyeyi; A Gasovya; D Mamah
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-26       Impact factor: 6.892

4.  The prevalance of binge eating disorder and associated psychiatric and substance use disorders in a student population in Kenya - towards a public health approach.

Authors:  Victoria N Mutiso; David M Ndetei; Esther N Muia; Rita K Alietsi; Lydia Onsinyo; Frida Kameti; Monicah Masake; Christine Musyimi; Daniel Mamah
Journal:  BMC Psychiatry       Date:  2022-02-16       Impact factor: 3.630

5.  Neurocognition in Kenyan youth at clinical high risk for psychosis.

Authors:  Daniel Mamah; Victoria N Mutiso; David M Ndetei
Journal:  Schizophr Res Cogn       Date:  2021-05-25

6.  Medicinal Plants Used in the Treatment of Mental and Neurological Disorders in Ghana.

Authors:  Patrick Amoateng; Emmanuel Quansah; Thomas K Karikari; Alex Asase; Dorcas Osei-Safo; Kennedy Kwami Edem Kukuia; Isaac Kingsley Amponsah; Alexander K Nyarko
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-20       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.